We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USD icon
5751
ProShares Ultra Semiconductors
USD
$2.44B
$27K ﹤0.01%
7,216
USIO icon
5752
Usio Inc
USIO
$58.8M
$27K ﹤0.01%
13,900
+13,898
+694,900% +$24.1K
SBT
5753
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$27K ﹤0.01%
7,720
+5,956
+338% +$19.6K
PSMG
5754
DELISTED
Invesco Growth Multi-Asset Allocation ETF
PSMG
$27K ﹤0.01%
2,000
GFLU
5755
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
$27K ﹤0.01%
+539
New +$25.4K
HTGM
5756
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$27K ﹤0.01%
210
+195
+1,300% +$17.2K
CHPMU
5757
DELISTED
CHP Merger Corp. Unit
CHPMU
$27K ﹤0.01%
2,629
-3,000
-53% -$30.1K
MRLN
5758
DELISTED
Marlin Business Services Corp
MRLN
$27K ﹤0.01%
3,196
+1,807
+130% +$14K
MJCO
5759
DELISTED
Majesco
MJCO
$27K ﹤0.01%
3,503
+1,726
+97% +$10.9K
ROSE
5760
DELISTED
Rosehill Resources Inc. Class A
ROSE
$27K ﹤0.01%
38,096
+36,985
+3,329% +$17.8K
ADME icon
5761
Aptus Behavioral Momentum ETF
ADME
$289M
$26K ﹤0.01%
+804
New +$24.7K
CCAP icon
5762
Crescent Capital BDC
CCAP
$403M
$26K ﹤0.01%
2,021
-84,282
-98% -$970K
CKX icon
5763
CKX Lands
CKX
$26K ﹤0.01%
3,233
CRIS icon
5764
Curis
CRIS
$9.78M
$26K ﹤0.01%
55
-1
-2% -$369
DAX icon
5765
Global X DAX Germany ETF
DAX
$230M
$26K ﹤0.01%
1,000
FID icon
5766
First Trust Exchange-Traded Fund VI First Trust S&P International Dividend Aristocrats ETF
FID
$168M
$26K ﹤0.01%
1,858
-1,501
-45% -$20.6K
FLNT
5767
Fluent
FLNT
$102M
$26K ﹤0.01%
2,430
+1,080
+80% +$12.1K
ULBI icon
5768
Ultralife
ULBI
$86.4M
$26K ﹤0.01%
3,632
+2,807
+340% +$20.5K
VERO
5769
DELISTED
Venus Concept
VERO
$26K ﹤0.01%
44
+34
+340% +$21.7K
WVVI icon
5770
Willamette Valley Vineyards
WVVI
$12.7M
$26K ﹤0.01%
4,300
PAMT
5771
PAMT Corp
PAMT
$337M
$26K ﹤0.01%
3,436
+1,636
+91% +$13.6K
FUV
5772
DELISTED
Arcimoto, Inc. Common Stock
FUV
$26K ﹤0.01%
249
+117
+89% +$5.83K
SRT
5773
DELISTED
Startek Inc.
SRT
$26K ﹤0.01%
5,179
+2,893
+127% +$11.4K
SVBI
5774
DELISTED
Severn Bancorp Inc/MD
SVBI
$26K ﹤0.01%
4,025
OLD
5775
DELISTED
The Long-Term Care ETF
OLD
$26K ﹤0.01%
1,077
+595
+123% +$13K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.